125 related articles for article (PubMed ID: 11368409)
1. Suppression of pRB expression in normal human mammary epithelial cells is associated with resistance to all-trans-retinoic acid but not N-(4-hydroxylphenyl)-retinamide.
Dietze EC; Yee L; Seewaldt VL
Breast Cancer Res Treat; 2001 Mar; 66(1):41-50. PubMed ID: 11368409
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid-mediated G1-S-phase arrest of normal human mammary epithelial cells is independent of the level of p53 protein expression.
Seewaldt VL; Dietze EC; Johnson BS; Collins SJ; Parker MB
Cell Growth Differ; 1999 Jan; 10(1):49-59. PubMed ID: 9950218
[TBL] [Abstract][Full Text] [Related]
3. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.
Panigone S; Debernardi S; Taya Y; Fontanella E; Airoldi R; Delia D
Oncogene; 2000 Aug; 19(35):4035-41. PubMed ID: 10962560
[TBL] [Abstract][Full Text] [Related]
4. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
Kazmi SM; Plante RK; Visconti V; Lau CY
Cancer Res; 1996 Mar; 56(5):1056-62. PubMed ID: 8640761
[TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of mitochondrial changes precede induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in MCF7 breast cancer cells.
Poot M; Hosier S; Swisshelm K
Exp Cell Res; 2002 Sep; 279(1):128-40. PubMed ID: 12213221
[TBL] [Abstract][Full Text] [Related]
6. All-trans-retinoic acid mediates G1 arrest but not apoptosis of normal human mammary epithelial cells.
Seewaldt VL; Kim JH; Caldwell LE; Johnson BS; Swisshelm K; Collins SJ
Cell Growth Differ; 1997 Jun; 8(6):631-41. PubMed ID: 9185997
[TBL] [Abstract][Full Text] [Related]
7. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma.
Sheikh MS; Shao ZM; Li XS; Ordonez JV; Conley BA; Wu S; Dawson MI; Han QX; Chao WR; Quick T
Carcinogenesis; 1995 Oct; 16(10):2477-86. PubMed ID: 7586155
[TBL] [Abstract][Full Text] [Related]
8. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
Ohlmann CH; Jung C; Jaques G
Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
[TBL] [Abstract][Full Text] [Related]
10. Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line.
Holmes WF; Soprano DR; Soprano KJ
J Biol Chem; 2002 Nov; 277(47):45408-19. PubMed ID: 12237293
[TBL] [Abstract][Full Text] [Related]
11. Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells.
Zou C; Zhou J; Qian L; Feugang JM; Liu J; Wang X; Wu S; Ding H; Zou C; Liebert M; Grossman HB
Front Biosci; 2006 Sep; 11():2007-16. PubMed ID: 16720286
[TBL] [Abstract][Full Text] [Related]
12. Stage-specific effect of N-(4-hydroxyphenyl)retinamide on cell growth in squamous cell carcinogenesis.
Kabbout M; Hatoum A; Abou-Lteif G; Chakroun I; Homaidan FR; Darwiche N
Mol Carcinog; 2004 May; 40(1):12-23. PubMed ID: 15108326
[TBL] [Abstract][Full Text] [Related]
13. N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL).
Faderl S; Lotan R; Kantarjian HM; Harris D; Van Q; Estrov Z
Leuk Res; 2003 Mar; 27(3):259-66. PubMed ID: 12537979
[TBL] [Abstract][Full Text] [Related]
14. N-(4-hydroxyphenyl)retinamide induces apoptosis in T lymphoma and T lymphoblastoid leukemia cells.
Chan LN; Zhang S; Shao J; Waikel R; Thompson EA; Chan TS
Leuk Lymphoma; 1997 Apr; 25(3-4):271-80. PubMed ID: 9168437
[TBL] [Abstract][Full Text] [Related]
15. Dysregulated expression of cyclin D1 in normal human mammary epithelial cells inhibits all-trans-retinoic acid-mediated G0/G1-phase arrest and differentiation in vitro.
Seewaldt VL; Kim JH; Parker MB; Dietze EC; Srinivasan KV; Caldwell LE
Exp Cell Res; 1999 May; 249(1):70-85. PubMed ID: 10328955
[TBL] [Abstract][Full Text] [Related]
16. Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/p300.
Dietze EC; Caldwell LE; Marcom K; Collins SJ; Yee L; Swisshelm K; Hobbs KB; Bean GR; Seewaldt VL
Microsc Res Tech; 2002 Oct; 59(1):23-40. PubMed ID: 12242694
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR).
Webber MM; Bello-DeOcampo D; Quader S; Deocampo ND; Metcalfe WS; Sharp RM
Clin Exp Metastasis; 1999 May; 17(3):255-63. PubMed ID: 10432011
[TBL] [Abstract][Full Text] [Related]
18. N-(4-hydroxyphenyl)-retinamide selectively increases All-TRANS retinoic acid inhibitory effects in HER2/NEU-overexpressing breast cancer cells.
Lim SJ; Gutiérrez-Puente Y; Tari AM
Tumour Biol; 2002; 23(5):279-86. PubMed ID: 12595744
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
[TBL] [Abstract][Full Text] [Related]
20. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
Delia D; Aiello A; Lombardi L; Pelicci PG; Grignani F; Grignani F; Formelli F; Menard S; Costa A; Veronesi U
Cancer Res; 1993 Dec; 53(24):6036-41. PubMed ID: 8261419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
